Print ISSN: 2155-3769/2689-5293 | E-ISSN: 2689-5307
2 Articles
2020 Year
Vol. 14 Volume

Research Articles

2

Docetaxel plus Androgen Deprivation Therapy as First-Line Treatment in High Volume Metastatic Hormone-Sensitive Prostate Cancer

Cairo University, Faculty of Medicine, Egypt

BACKGROUND: The addition of docetaxel to androgen deprivation therapy (ADT) as a first-line treatment has shown significant improvement in overall survival for patients with high volume metastatic hor...

View Article →